Cargando…
The design and statistical aspects of VIETNARMS: a strategic post-licensing trial of multiple oral direct-acting antiviral hepatitis C treatment strategies in Vietnam
BACKGROUND: Eliminating hepatitis C is hampered by the costs of direct-acting antiviral treatment and the need to treat hard-to-reach populations. Access could be widened by shortening or simplifying treatment, but limited research means it is unclear which approaches could achieve sufficiently high...
Autores principales: | McCabe, Leanne, White, Ian R., Chau, Nguyen Van Vinh, Barnes, Eleanor, Pett, Sarah L., Cooke, Graham S., Walker, A. Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236096/ https://www.ncbi.nlm.nih.gov/pubmed/32423467 http://dx.doi.org/10.1186/s13063-020-04350-x |
Ejemplares similares
-
Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus
por: Sy, Aminata, et al.
Publicado: (2023) -
High Cure Rates for Hepatitis C Virus Genotype 6 in Advanced Liver Fibrosis With 12 Weeks Sofosbuvir and Daclatasvir: The Vietnam SEARCH Study
por: Flower, Barnaby, et al.
Publicado: (2021) -
Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C
por: Cooke, Graham S., et al.
Publicado: (2021) -
Interpreting discordant indirect and multiple treatment comparison meta-analyses: an evaluation of direct acting antivirals for chronic hepatitis C infection
por: Druyts, Eric, et al.
Publicado: (2013) -
Electronic health records to capture primary outcome measures: two case studies in HIV prevention research
por: Dunn, David, et al.
Publicado: (2023)